Document Detail


Calcium channel blockers versus ACE inhibitors as antihypertensives in polycystic kidney disease.
MedLine Citation:
PMID:  8730344     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of calcium channel blockers (CCBs) and angiotensin converting enzyme (ACE) inhibitors on blood pressure and the progression of renal dysfunction were compared in hypertensive patients with polycystic kidney disease (PKD). Twenty-six patients with PKD and hypertension who had been treated with other antihypertensive agents, such as diuretics, beta-blockers, or alpha-methyldopa, were followed up for two years, during which their blood pressure and renal function were monitored. Patients were divided into two groups classified according to the type of antihypertensive agents given. Group 1 (n = 14) received CCBs, while group 2 (n = 12) received ACE inhibitors. No significant differences were found in their blood pressure control and serum creatinine levels throughout the study. The creatinine clearances were decreased in both groups. However, the decreases in creatinine clearance were smaller (p < 0.05) in the group treated with CCBs. In addition, two patients in group 2 showed rapid increases in serum creatinine. Our data suggest that CCBs reduced blood pressure effectively and preserved renal function in PKD patients at least as well as ACE inhibitors.
Authors:
Y Kanno; H Suzuki; H Okada; T Takenaka; T Saruta
Related Documents :
14564134 - The differences between ace inhibitor-treated and calcium channel blocker-treated hyper...
3534854 - Influence of captopril on intracellular ions--a possible mode of action.
18679784 - Pulsatile mechanical pressure promotes angiotensin-converting enzyme expression in aort...
7018794 - Effect of the converting-enzyme inhibitor sq 14 225 (captopril) in early one-kidney, on...
3177854 - Blood pressure response of neonates to tracheal intubation.
7589654 - Elevated tubal perfusion pressures during selective salpingography are highly suggestiv...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  QJM : monthly journal of the Association of Physicians     Volume:  89     ISSN:  1460-2725     ISO Abbreviation:  QJM     Publication Date:  1996 Jan 
Date Detail:
Created Date:  1996-10-24     Completed Date:  1996-10-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9438285     Medline TA:  QJM     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  65-70     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Keio University, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects
Calcium Channel Blockers / therapeutic use*
Captopril / therapeutic use
Enalapril / therapeutic use
Female
Humans
Hypertension / complications,  drug therapy*
Male
Middle Aged
Nicardipine / therapeutic use
Nifedipine / therapeutic use
Polycystic Kidney Diseases / complications*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Calcium Channel Blockers; 21829-25-4/Nifedipine; 55985-32-5/Nicardipine; 62571-86-2/Captopril; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherap...
Next Document:  Bacterial meningitis in patients with nasopharyngeal carcinoma.